ISPD Collaboration Corner

The ISPD Collaboration Corner is a pathway for building inter-disciplinary research in fetal conditions and treatment. We invite interested researchers who are seeking additional investigators or patients to have their study posted here for a period of 30 days by completing the submission form provided on this page.

Listed below are studies seeking additional investigators and/or patients. If you are interested in participating in one of the studies listed on this page, please use the email address provided to contact the researcher directly.

Collaboration Posters — ISPD also accepts abstracts for collaboration posters at the annual conference. This poster format makes a great conversation starter for researchers who are seeking collaboration on research, feedback on study design, etc. Look for a link to the next upcoming conference on the ISPD home page.

 

Principal Investigators

Are you seeking additional investigators and/or patients for your study? Please complete and submit the study listing form to have your study listed on this page.

Submit a Study Listing

If you prefer, you may use a PDF submission form instead.

Studies will be posted for 366 days. If you need to make changes to your posting during that time, please contact the ISPD webmaster.

STUDY POSTINGS

 2021-07-29_UErlangen-Nurnberg_SchneiderH
(7/29/2021)
 
   

Study Name:  Intraamniotic Administrations of ER004 in Male Subjects With X-linked Hypohidrotic Ectodermal Dysplasia (EDELIFE)

Principal Investigator: Holm Schneider, M.D., University Erlangen-Nürnberg, holm.schneider@uk-erlangen.de

Collaborating Investigator(s) Sought: No

Patients Sought:  Pregnant women carrying a male fetus affected by XLHED (confirmed by sonographic diagnosis of a significantly reduced number of fetal tooth germs or by genetic diagnosis of an EDA mutation in the fetus). Enrolment requires getting in touch with the study site prior to gestational week 26.

Additional Information:  This is a prospective, open-label, genotype-match controlled, multicenter clinical trial to investigate the efficacy and safety of intraamniotic administration of ER004, an ectodysplasin A replacement protein, as a prenatal treatment for male subjects with XLHED.

Funding:  EspeRare Foundation, German Federal Ministry of Education and Research, and Pierre Fabre



 

If no studies are listed, there have been no studies submitted within the last 366 days. Please return to check for further postings.

ISPD does not review nor specifically endorse any study posted to the Collaboration Corner. ISPD acts solely in the capacity as a facilitator. The submitter is responsible for the accuracy of the information provided and agrees to having the email address of the principal investigator posted on the ISPD website where it is visible to the general public.